Week30, 2023
1. Influenza activity remained minimal nationwide, with 1.0% of clinical lab specimens testing positive; 54.2% were Influenza A and 45.8% were Influenza B.
2. Public health labs reported low positivity, with 64.3% Influenza A (93.7% H1N1 and 6.3% H3N2) and 35.7% Influenza B (Victoria lineage exclusively).
3. Outpatient visits for ILI accounted for 1.2% of visits, with higher percentages in children under 5 years (4.2%) but minimal activity overall.
4. Two novel Influenza A variant cases (H3v and H1N2v) linked to swine exposure were reported, with no sustained human-to-human transmission observed.
5. Hospitalization rates included 649 admissions for laboratory-confirmed influenza, while surveillance for FluSurv-NET concluded data collection for this season.
6. Mortality surveillance reported 5.7% of deaths due to pneumonia, influenza, and/or COVID-19, slightly exceeding the epidemic threshold (5.6%). Influenza contributed to four deaths.
7. Two pediatric deaths associated with Influenza A (H1N1) were added to the cumulative total of 166 for the 2022-23 season.
8. Multiple respiratory viruses, including RSV and SARS-CoV-2, continue to co-circulate and contribute to respiratory illness visits.
9. Vaccination updates or trends were not explicitly mentioned in the report.
10. CDC projections for future flu activity remain unquantified but emphasize ongoing surveillance and preparedness.